IP Library Granted Patent US 9,289,502
Granted Patent B2
US 9,289,502 · App. 13/790,922 · Granted Mar 22, 2016

Preparation of oligo conjugates

Inventors: Brian M. Frezza (Redwood City, CA); Courtney E. Webster (Palo Alto, CA); Daniel J. Kleinbaum (Redwood City, CA)
Assignee: EMERALD THERAPEUTICS, INC.
A61K47/48092C07H21/00Y10S977/932
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,289,502
App. No.
13/790,922
Granted
Mar 22, 2016
Kind
B2
Abstract

Conjugated molecules are prepared that comprise a predetermined number of oligo conjugation components. The conjugated molecules also may comprise one or more detectable labels. Preparation of these molecules can be implemented according to an asymmetric or a symmetric conjugation strategy.

Claims (285)

1. A method of preparing a compound of the formula

comprising

(i) attaching a conjugation component of the formula

wherein R 2 is R 2a or R 2ap ,

to a solid support

to form a compound of the formula

(ii) when R 2 is R 2ap , converting

(iii) contacting

with a conjugation component of the formula

wherein R 3 is R 3a , or R 3ap ;

to form

(iv) when R 3 is R 3ap , converting

to

and

(v) contacting

with a conjugation component of the formula

to provide the compound of the formula

wherein:

is a solid support material;

are independently an oligo, where each oligo is independently a polymer, having from 2 to about 150 covalently linked monomer units, that is characterized by a sequence of 2′-deoxyribosenucleotide residues (DNA), ribonucleotide residues (RNA), and peptide nucleic acids (PNAs), or a combination thereof;

R 1a and R 1b are complementary conjugation functionalities and L 1 is conjugate linker, and R 1a , R 1b , and L 1 are

(a) R 1a is azido, R 1b is —C≡C—R 23 , and L 1 is

or

(b) R 1a is —NHR 23 , R 1b is carboxy, and L 1 is —NR 23 C(═O)—, or

(c) R 1a is carboxy, R 1b is —NHR 23 , and L 1 is —C(═O)NR 23 —, or

(d) R 1a is —NHR 23 , R 1b is halo, and L 1 is —NR 23 —, or

(e) R 1a is —O—P(═O)(OH)(X), R 1b is hydroxy, and L 1 is —O—P(═O)(OH)—O—, or

(f) R 1a is —O—P(═O)(OH)(X), R 1b is —NHR 23 , and L 1 is —O—P(═O)(OH)—NR 23 —, or

(g) R 1a is —O—P(═O)(OH)(X), R 1b is thio, and L 1 is —O—P(═O)(OH)—S—, or

(h) R 1a is halo, R 1b is thio, and L 1 is —S—, or

(i) R 1a is

R 1b is thio, and L 1 is

or

(j) R 1a is —C≡C—R 23 , R 1b is azido, and L 1 is

or

(k) R 1a is halo, R 1b is —NHR 23 , and L 1 is —NR 23 —, or

(l) R 1a is hydroxy, R 1b is —O—P(═O)(OH)(X), and L 1 is —O—P(═O)(OH)—O—, or

(m) R 1a is —NHR 23 , R 1b is —O—P(═O)(OH)(X), and L 1 is —NR 23 —P(═O)(OH)—O—, or

(n) R 1a is thio, R 1b is —O—P(═O)(OH)(X), and L 1 is —S—P(═O)(OH)—O—, or

(o) R 1a is —O—P(═O)(OH)SH, R 1b is —X, and L 1 is —O—P(═O)(OH)—S—, or

(p) R 1a is —X, R 1b is —O—P(═O)(OH)SH, and L 1 is —S—P(═O)(OH)—O—, or

(q) R 1a is —(CR 25 R 25 ) s C(═O)OR 23 , R 1b is —NHR 23 , L 1 is —(CR 25 R 25 ) s C(═O)NR 23 —, or

(r) R 1a is —NHR 23 , R 1b is —(CR 25 R 25 ) s C(═O)OR 23 , L 1 is —NR 23 C(═O)—(CR 25 R 25 ) s —, or

(s) R 1a is thio, R 1b is halo, and L 1 is —S—, or

(t) R 1a is thio, R 1b is

and L 1 is

(u) R 1a is —SH, R 1b is —O—P(═O)(OH)(O—(CH 2 ) n —SH) and L 1 is —S—S—(CH 2 ) n —O—P(OH)(═O)—O—;

R 2a and R 2b are complementary conjugation functionalities and L 2 is conjugate linker, and R 2ap , R 2a , R 2b , and L 2 are

(a′) R 2ap is halo, R 2a is azido, R 2b is —C≡C—R 23 , and L 2 is

or

(b′) R 2ap is —NR 23 Pr, R 2a is —NHR 23 , R 2b is carboxy, and L 2 is —NR 23 C(═O)—, or

(c′) R 2ap is carboxy ester, R 2a is carboxy, R 2b is —NHR 23 , and L 2 is —C(═O)NR 23 —, or

(d′) R 2ap is —NR 23 Pr, R 2a is —NHR 23 , R 2b is halo, and L 2 is —NR 23 —, or

(e′) R 2ap is —OH, phosphate or phosphate ester, R 2a is —O—P(═O)(OH)(X), R 2b is hydroxy, and L 2 is —O—P(═O)(OH)—O—, or

(f) R 2ap is —OH, phosphate or phosphate ester, R 2a is —O—P(═O)(OH)(X), R 2b is —NHR 23 , and L 2 is —O—P(═O)(OH)—NR 23 —, or

(g′) R 2ap is —OH, phosphate or phosphate ester, R 2a is —O—P(═O)(OH)(X), R 2b is thio, and L 2 is —O—P(═O)(OH)—S—, or

(h′) R 2a is —X, R 2b is thio, and L 2 is —S—, or

(i′) R 2a is

R 2b is thio, and L 2 is

or

(j′) R 2a is —C≡C—R 23 , R 2b is azido, and L 2 is

or

(k′) R 2a is halo, R 2b is —NHR 23 , and L 2 is —NR 23 —, or

(l′) R 2a is hydroxy, R 2b is —O—P(═O)(OH)(X), and L 2 is —O—P(═O)(OH)—O—, or

(m′) R 2a is —NHR 23 , R 2b is —O—P(═O)(OH)(X), and L 2 is —NR 23 —P(═O)(OH)—O—, or

(n′) R 2a is thio, R 2b is —O—P(═O)(OH)(X), and L 2 is —S—P(═O)(OH)—O—, or

(o′) R 2ap is —O—P(═O)(OH)SR 24 , R 2a is —O—P(═O)(OH)SH, R 2b is —X, and L 2 is —O—P(═O)(OH)—S—, or

(p′) R 2a is —X, R 2b is —O—P(═O)(OH)SH, and L 2 is —S—P(═O)(OH)—O—, or

(q′) R 2a is —(CR 25 R 25 ) s C(═O)OR 23 , R 2b is —NHR 23 , L 2 is —(CR 25 R 25 ) s C(═O)NR 23 —, or

(r′) R 2a is —NHR 23 , R 2b is —(CR 25 R 25 ) s C(═O)OR 23 , L 2 is —NR 23 C(═O)—(CR 25 R 25 ) s —, or

(s′) R 2a is thio, R 2b is halo, and L 2 is —S—, or

(t′) R 2a is thio, R 2b is

and L 2 is

or

(u′) R 2a is —SH, R 2b is —O—P(═O)(OH)(O—(CH 2 ) n —SH) and L 2 is —S—S—(CH 2 ) n —O—P(OH)(═O)—O—;

R 3a and R 3b are complementary conjugation functionalities and L 3 is conjugate linker, and R 3ap , R 3a , R 3b , and L 3 are

(a″) R 3ap is halo, R 3a is azido, R 3b is —C≡C—R 23 , and L 3 is

or

(b″) R 3a p is —NR 23 Pr, R 3a is —NHR 23 , R 3b is carboxy, and L 3 is —NR 23 C(═O)—, or

(c″) R 3ap is carboxy ester, R 3a is carboxy, R 3b is —NHR 23 , and L 3 is —C(═O)NR 23 —, or

(d″) R 3ap is —NR 23 Pr, R 3a is —NHR 23 , R 3b is halo, and L 3 is —NR 23 —, or

(e″) R 3ap is —OH, phosphate or phosphate ester, R 3a is —O—P(═O)(OH)(X), R 3b is hydroxy, and L 3 is —O—P(═O)(OH)—O—, or

(f″) R 3ap is —OH, phosphate or phosphate ester, R 3a is —O—P(═O)(OH)(X), R 3b is —NHR 23 , and L 3 is —O—P(═O)(OH)—NR 23 —, or

(g″) R 3ap is —OH, phosphate or phosphate ester, R 3a is —O—P(═O)(OH)(X), R 3b is thio, and L 3 is —O—P(═O)(OH)—S—, or

(h″) R 3a is —X, R 3b is thio, and L 3 is —S—, or

(i″) R 3a is

R 3b is thio, and L 3 is

or

(j″) R 3a is —C≡C—R 23 , R 3b is azido, and L 3 is

or

(k″) R 3a is halo, R 3b is —NHR 23 , and L 3 is —NR 23 —, or

(l″) R 3a is hydroxy, R 2b is —O—P(═O)(OH)(X), and L 3 is —O—P(═O)(OH)—O—, or

(m″) R 3a is —NHR 23 , R 3b is —O—P(═O)(OH)(X), and L 3 is —NR 23 —P(═O)(OH)—O—, or

(n″) R 3a is thio, R 3b is —O—P(═O)(OH)(X), and L 3 is —S—P(═O)(OH)—O—, or

(o″) R 3ap is —O—P(═O)(OH)SR 24 , R 3a is —O—P(═O)(OH)SH, R 3b is —X, and L 3 is —O—P(═O)(OH)—S—, or

(p″) R 3a is —X, R 3b is —O—P(═O)(OH)SH, and L 3 is —S—P(═O)(OH)—O—, or

(q″) R 3a is —(CR 25 R 25 ) s C(═O)OR 23 , R 3b is —NHR 23 , L 3 is —(CR 25 R 25 ) s C(═O)NR 23 —, or

(r″) R 3a is —NHR 23 , R 3b is —(CR 25 R 25 ) s C(═O)OR 23 , L 3 is —NR 23 C(═O)—(CR 25 R 25 ) s —, or

(s″) R 3a is thio, R 3b is —X, and L 3 is —S—, or

(t″) R 3a is thio, R 3b is

and L 3 is

or

(u″) R 3a is —SH, R 3b is —O—P(═O)(OH)(O—(CH 2 ) n —SH) and L 3 is —S—S—(CH 2 ) n —O—P(OH)(═O)—O—;

R 4 is selected from the group consisting of R 3a , R 3ap , halo, —NR 23 Pr, —OH, —O—P(═O)(OH)SR 24 , carboxy ester, phosphate, phosphate ester, azido, —C≡C—R 23 , —NHR 23 , carboxy, hydroxy, —(CR 25 R 25 ) s C(═O)OR 23 , —O—P(═O)(OH)SH, or —O—P(═O)(OH)Br, or an oligo;

X is chlorine, bromine, fluorine, tosylate, mesylate, triflate, or dimethoxy triflate,

n is 1, 2, 3, 4, 5, or 6;

R 23 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, cycloalkynyl, substituted cycloalkynyl, heteroaryl, substituted heteroaryl, heterocyclic, and substituted heterocyclic;

Pr is an amino protecting group;

R 24 is trityl or benzyl;

R 25 is hydrogen or C 1-6 alkyl;

n is 1, 2, 3, 4, 5, or 6;

s is an integer of greater than 1;

provided that R 2 does not react with R 1a or R 1b , R 3 does not react with R 2a or R 2b and R 4 does not react with R 3a or R 3b ;

- - - represents the point of connection to the part of the solid support-bound conjugated molecule that is closer to

and represents the point of connection to the part of the solid support-bound conjugated molecule that is further away from

2. The method of claim 1 for preparing a compound of the formula

comprising

(i) attaching a compound of the formula

to a solid support

to form a compound of the formula

and

(iii) reacting

with a compound of the formula

to form

wherein:

is a solid support material;

are independently an oligo;

R 1a and R 1b are complementary conjugation functionalities and L 1 is conjugate linker, R 2a and R 2b are complementary conjugation functionalities and L 2 is conjugate linker, and R 1a , R 1b , L 1 , R 2a , R 2b , L 2 , and R 3a are selected from

R 1a , R 2a , or R 3a

R 1b or R 2b

L 1 or L 2

—C≡C—R 23

azido

azido

—C≡C—R 23

carboxy

—NHR 23

—C(═O)NR 23 —

—NHR 23

carboxy

—NR 23 C(═O)—

halo

—NHR 23

—NR 23 —

—NR 23

halo

—NR 23 —

hydroxy

—O—P(═O)(OH)(X)

—O—P(═O)(OH)—O—

—O—P(═O)(OH)(X)

hydroxy

—O—P(═O)(OH)—O—

—NHR 23

—O—P(═O)(OH)(X)

—NR 23 —P(═O)(OH)—O—

—O—P(═O)(OH)(X)

—NHR 23

—O—P(═O)(OH)—NR 23 —

thio

—O—P(═O)(OH)(X)

—S—P(═O)(OH)—O—

—O—P(═O)(OH)(X)

thio

—O—P(═O)(OH)—S—

thio

—X

—S—

—X

thio

—S—

—O—P(═O)(OH)SH

—X

—O—P(═O)(OH)—S—

—X

—O—P(═O)(OH)SH

—S—P(═O)(OH)—O—

—(CR 25 R 25 ) s C(═O)OR 23

—NHR 23

—(CR 25 R 25 ) s C(═O)NR 23 —

—NHR 23

—(CR 25 R 25 ) s C(═O)OR 23

—NR 23 C(═O)—(CR 25 R 25 ) s —

thio

thio

—SH

—O—P(═O)(OH)(O—(CH 2 ) n —SH)

—S—S—(CH 2 ) n —O—P(OH)(═O)—O—

wherein the selection of R 1a , R 2a , or R 3a is independent of each other provided that L 1 and L 2 are different, R 2a does not react with R 1a or R 1b , and R 3a does not react with R 2a or R 2b ;

X is chlorine, bromine, fluorine, tosylate, mesylate, triflate, or dimethoxy triflate;

R 23 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, cycloalkynyl, substituted cycloalkynyl, heteroaryl, substituted heteroaryl, heterocyclic, and substituted heterocyclic;

R 25 is hydrogen or C 1-6 alkyl;

s is an integer of greater than 1;

- - - represents the point of connection to the part of the solid support-bound conjugated molecule that is closer to

and represents the point of connection to the part of the solid support-bound conjugated molecule that is further away from

3. A method of preparing a compound of the formula

comprising

cleaving the bond between

and L 1 of the compound of the formula

thereby obtaining

wherein:

the compound of

is prepared according to the method of claim 1 ;

L 1 , L 2 , R 3 , R 4 ,

are as defined in claim 1 ; and

Z is —OH, OH—(C 1 -C 10 )alkylene-, —COOH, NH 2 C(O)—, NH 2 NH—C(O)—, COOH—(C 1 -C 10 )alkylene-, NH 2 C(O)—(C 1 -C 10 )alkylene-, NH 2 NH—C(O)—(C 1 -C 10 )alkylene-, CH 2 ═CH—(C 1 -C 10 )alkylene-, C≡C—(C 1 -C 10 )alkylene- or HS—(C 1 -C 10 )alkylene- and any alkylene is optionally substituted by one or more groups selected from —OH, halogen, —NHR″, —NHC(O)—(C 1 -C 10 )alkylene-C≡CH, and —NHC(O)—(C 1 -C 10 )alkylene-CH═CH 2 ;

R″ is selected from (C 1 -C 10 )alkyl, (C 3 -C 10 )cycloalkyl, or (C 3 -C 10 )aryl.

4. The method of claim 1 , wherein the method further comprises preparing a compound of the formula

comprising

(i) converting the compound of formula

to

and

(ii) contacting

with a conjugation component of the formula

wherein steps (i) and (ii) are performed a sufficient number of times to provide the compound of the formula

wherein:

n is an integer between 2 and 25, and

L 1 , L 2 , R 3a , R 4 ,

are as defined in claim 1 .

5. A method for preparing a compound of the formula

comprising cleaving a compound of formula

from the solid support, wherein

Z is —OH, OH—(C 1 -C 10 )alkylene-, —COOH, NH 2 C(O)—, NH 2 NH—C(O)—, COOH—(C 1 -C 10 )alkylene-, NH 2 C(O)—(C 1 -C 10 )alkylene-, NH 2 NH—C(O)—(C 1 -C 10 )alkylene-, CH 2 ═CH—(C 1 -C 10 )alkylene-, C≡C—(C 1 -C 10 )alkylene- or HS—(C 1 -C 10 )alkylene- and the alkylene can be optionally substituted by one or more groups selected from —OH, halogen, —NHR″, —NHC(O)—(C 1 -C 10 )alkylene-C≡CH, or —NHC(O)—(C 1 -C 10 )alkylene-CH═CH 2 ;

R″ is (C 1 -C 10 )alkyl, (C 3 -C 10 )cycloalkyl, or (C 3 -C 10 )aryl; and

L 1 , L 2 , L 3 , R 4 ,

are as defined in claim 1 .

6. A method for preparing a compound of the formula

comprising cleaving a compound of formula

from

wherein

Z is —OH, OH—(C 1 -C 10 )alkylene-, —COOH, NH 2 C(O)—, NH 2 NH—C(O)—, COOH—(C 1 -C 10 )alkylene-, NH 2 C(O)—(C 1 -C 10 )alkylene-, NH 2 NH—C(O)—(C 1 -C 10 )alkylene-, CH 2 ═CH—(C 1 -C 10 )alkylene-, C≡C—(C 1 -C 10 )alkylene- or HS—(C 1 -C 10 )alkylene- and the alkylene can be optionally substituted by one or more groups selected from —OH, halogen, —NHR″, —NHC(O)—(C 1 -C 10 )alkylene-C≡CH, or —NHC(O)—(C 1 -C 10 )alkylene-CH═CH 2 ;

R″ is (C 1 -C 10 )alkyl, (C 3 -C 10 )cycloalkyl, or (C 3 -C 10 )aryl; and

n,

L 1 , L 2 , L 3 , L 4 ,

are as defined in claim 4 .

7. A method of preparing a compound of the formula

comprising

(i) attaching a conjugation component of the formula

wherein R 2 is R 2a or R 2ap ,

to a solid support

to form a compound of the formula

(ii) when R 2 is R 2ap , converting

to

(iii) contacting

with a conjugation component of the formula

wherein R 3 is R 3a , or R 3ap ;

to form

(iv) when R 3 is R 3ap , converting

to

and

(v) contacting

with a conjugation component of the formula

to provide the compound of the formula

wherein:

is a solid support material;

are independently an oligo, where each oligo is independently a polymer, having from 2 to about 150 covalently linked monomer units, that is characterized by a sequence of 2′-deoxyribosenucleotide residues (DNA), ribonucleotide residues (RNA), and peptide nucleic acids (PNAs), or a combination thereof;

wherein

(a) R 1a is azido, R 1b is —C≡C—R 23 , and L 1 is

(a′) R 2ap is halo, R 2a is azido, R 2b is —C═C—R 23 , and L 2 is

(a″) R 3ap is halo, R 3a is azido, R 3b is —C≡C—R 23 , and L 3 is

or

R 4 is selected from the group consisting of R 3a , R 3ap , halo, —NR 23 Pr, —OH, —O—P(═O)(OH)SR 24 , carboxy ester, phosphate, phosphate ester, azido, —C≡C—R 23 , —NHR 23 , carboxy, hydroxy, —(CR 25 R 25 ) s C(═O)OR 23 , —O—P(═O)(OH)SH, or —O—P(═O)(OH)Br, or an oligo;

n is 1, 2, 3, 4, 5, or 6;

R 23 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, cycloalkynyl, substituted cycloalkynyl, heteroaryl, substituted heteroaryl, heterocyclic, and substituted heterocyclic;

Pr is an amino protecting group;

R 24 is trityl or benzyl;

R 25 is hydrogen or C 1-6 alkyl;

s is an integer of greater than 1;

provided that R 2 does not react with R 1a or R 1b , R 3 does not react with R 2a or R 2b and R 4 does not react with R 3a or R 3b ;

- - - represents the point of connection to the part of the solid support-bound conjugated molecule that is closer to

and represents the point of connection to the part of the solid support-bound conjugated molecule that is further away from

8. The method of claim 7 , wherein the method further comprises preparing a compound of the formula

comprising

(i) converting the compound of formula

to

(ii) when R 3 is R 3ap , converting

to

and

(iii) contacting

with a conjugation component of the formula

wherein steps (i), (ii) and (iii) are performed a sufficient number of times to provide the compound of the formula

wherein:

n is an integer between 2 and 25, and

L 1 , L 2 , L 3a , R 3b , R 4 ,

are as defined in claim 7 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2016
From: EMERALD CLOUD LAB, INC.
To: EMERALD THERAPEUTICS, INC.
Reel/Frame 040502/0234 →
CHANGE OF NAME Recorded Nov 30, 2016
From: EMERALD THERAPEUTICS, INC.
To: EMERALD CLOUD LAB, INC.
Reel/Frame 040773/0624 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2013
From: FREZZA, BRIAN M.; WEBSTER, COURTNEY E.; KLEINBAUM, DANIEL J.
To: EMERALD THERAPEUTICS, INC.
Reel/Frame 030572/0873 →
Continuity (1)
Related Publication 20140256911A1 · Sep 11, 2014